Multiple Analytical Approaches Reveal Distinct Gene-Environment Interactions in Smokers and Non Smokers in Lung Cancer by Ihsan, Rakhshan et al.
Multiple Analytical Approaches Reveal Distinct Gene-
Environment Interactions in Smokers and Non Smokers
in Lung Cancer
Rakhshan Ihsan
1, Pradeep Singh Chauhan
1, Ashwani Kumar Mishra
1, Dhirendra Singh Yadav
1, Mishi
Kaushal
1, Jagannath Dev Sharma
2, Eric Zomawia
3, Yogesh Verma
4, Sujala Kapur
1, Sunita Saxena
1*
1National Institute of Pathology (Indian Council of Medical Research) Safdarjung Hospital Campus, New Delhi, India, 2Dr. Bhubaneswar Borooah Cancer Institute, Gopi
Nath Nagar, Guwahati, Assam, India, 3Civil Hospital Aizawl, Mizoram, India, 4Sir Thutob Namgyal Memorial Hospital, Gangtok, Sikkim, India
Abstract
Complex disease such as cancer results from interactions of multiple genetic and environmental factors. Studying these
factors singularly cannot explain the underlying pathogenetic mechanism of the disease. Multi-analytical approach,
including logistic regression (LR), classification and regression tree (CART) and multifactor dimensionality reduction (MDR),
was applied in 188 lung cancer cases and 290 controls to explore high order interactions among xenobiotic metabolizing
genes and environmental risk factors. Smoking was identified as the predominant risk factor by all three analytical
approaches. Individually, CYP1A1*2A polymorphism was significantly associated with increased lung cancer risk
(OR=1.69;95%CI=1.11–2.59,p=0.01), whereas EPHX1 Tyr113His and SULT1A1 Arg213His conferred reduced risk
(OR=0.40;95%CI=0.25–0.65,p,0.001 and OR=0.51;95%CI=0.33–0.78,p=0.002 respectively). In smokers, EPHX1 Tyr113His
and SULT1A1 Arg213His polymorphisms reduced the risk of lung cancer, whereas CYP1A1*2A, CYP1A1*2C and GSTP1
Ile105Val imparted increased risk in non-smokers only. While exploring non-linear interactions through CART analysis,
smokers carrying the combination of EPHX1 113TC (Tyr/His), SULT1A1 213GG (Arg/Arg) or AA (His/His) and GSTM1 null
genotypes showed the highest risk for lung cancer (OR=3.73;95%CI=1.33–10.55,p=0.006), whereas combined effect of
CYP1A1*2A 6235CC or TC, SULT1A1 213GG (Arg/Arg) and betel quid chewing showed maximum risk in non-smokers
(OR=2.93;95%CI=1.15–7.51,p=0.01). MDR analysis identified two distinct predictor models for the risk of lung cancer in
smokers (tobacco chewing, EPHX1 Tyr113His, and SULT1A1 Arg213His) and non-smokers (CYP1A1*2A, GSTP1 Ile105Val and
SULT1A1 Arg213His) with testing balance accuracy (TBA) of 0.6436 and 0.6677 respectively. Interaction entropy
interpretations of MDR results showed non-additive interactions of tobacco chewing with SULT1A1 Arg213His and EPHX1
Tyr113His in smokers and SULT1A1 Arg213His with GSTP1 Ile105Val and CYP1A1*2C in nonsmokers. These results identified
distinct gene-gene and gene environment interactions in smokers and non-smokers, which confirms the importance of
multifactorial interaction in risk assessment of lung cancer.
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Introduction
Lung cancer is the most commonly diagnosed cancer and the
leading cause of cancer death globally [1]. In India it constitutes
6.2% of all cancers with approximately 58,000 incident cases
reported in 2008 and is the most frequent cancer in males [2].
North eastern (NE) part of India is showing a steady rise in cancer
incidences and lung cancer is among the ten leading sites, with the
highest age-adjusted incidence rate (AAR) in Mizoram state (24.5
in males and 26.3 in females). Aizwal district alone shows an AAR
of 36.0 in males and 38.7 in females which is almost three to ten
times higher than Delhi [3]. Incidence of lung cancer is also high
among males in Silchar and Imphal districts. High incidence rates
suggest role of both genetic as well as environmental factors such
as smoking, tobacco use and dietary carcinogen consumption.
Individuals possessing modified ability to metabolize carcino-
gens such as polycyclic aromatic hydrocarbons (PAH), which are
ubiquitous environmental, dietary, and tobacco carcinogens are at
increased risk of developing cancer. Thus genetic variants in
xenobiotic metabolizing genes can influence their clearance from
circulation and determine response to such carcinogens. The
phase I xenobiotic metabolizing enzymes like cytochrome P-450s
(CYPs), alcohol dehydrogenase (ALDH) and epoxide hydroxylase
(EPHX) usually activate the procarcinogens through oxidation and
dehydrogenation thereby converting them into reactive metabo-
lites. Phase II metabolic enzymes such as glutathione S-
transferases (GST), sulfotransferase (SULT) and N-acetyltransferase
(NAT) generally result in inactivation or detoxification of these
reactive metabolites. Equilibrium between expression and activity
levels of these xenobiotic-metabolizing enzymes of both phase I
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However, these pathways are also known to activate toxic and
carcinogenic chemicals to electrophilic forms that react irreversibly
with macromolecules such as proteins and nucleic acids leading to
carcinogenesis.
Single nucleotide polymorphisms (SNPs) in xenobiotic metab-
olizing genes have been studied extensively with risk of lung
cancer. A majority of these molecular epidemiological studies
consider only the main effects of these SNPs and their observed
strength of associations could be challenged by penetrance of the
genetic variant. Furthermore, a single locus cannot account for
genetic susceptibility in a complex disease such as cancer which
involves multiple genetic variations and gene-environment inter-
actions. Current evidences suggest that high order interactions in
multigenic approach allow more precise delineation of risk groups
[4,5].
In the present study, two data mining approaches, CART and
MDR were applied along with LR to detect high order gene-gene
and gene environment interactions. Both CART and MDR
assume model free and non-parametric methods of estimating
non-linear interactions with low false-positives even on relatively
small sample sizes. Model validation through permutation testing
and false positive report probabilities were also done to overcome
inaccurate estimation. Interaction entropy graphs were construct-
ed to interpret combination effects identified by MDR. To further
analyze possible effects of the EPHX1 and CYP1A1 SNPs, we
estimated their haplotype frequencies and risk imparted towards
lung cancer.
Materials and Methods
Study subjects
This study consisted of 188 histopathologically diagnosed lung
cancer cases registered at Dr. Bhubaneswar Borooah Cancer
Institute, Guwahati, Civil Hospital, Aizawl, and Sir Thutob
Namgyal Memorial Hospital, Gangtok, the collaborating centers
in north east India. Incident cases during the period of December
2006 to 2009 and willing to participate in the study were included.
290 voluntary, age (65 years) and sex matched individuals were
selected from the unrelated attendants who accompanied cancer
patients. This provided a readily available and cooperative source
of controls from the same socio-economic background as the cases
reducing confounding biases. As our collaborating centers were
public hospitals a large majority of subjects belonged to lower to
middle socio-economic background. Demographic data and
characteristics such as age, sex, smoking habit, usage of tobacco,
betel quid and alcohol, were obtained from subjects in a standard
questionnaire used for all the centers, in an in-person interview by
a trained data collector. A majority of cases and controls were
literate with full primary schooling and some upto the college level.
The occupational history of the study participants revealed that
most of them were farm laborers or engaged in petty jobs and the
nature of such jobs did not exposed them to any occupational
hazards. Any history of past or present illness was enquired or if
undergoing any medication at the time of enrolment. Patients with
only lung as their primary site of cancer were included. Any
subject with history of familial malignancy or pulmonary infectious
disease was excluded both from case and control. Final selected
controls were included on the basis of no history of any obvious
disease and those not taking any medication at the time of
recruitment. All subjects provided written informed consent for
participation in this research which was done under a protocol
approved by the institutional ethics committee of Regional
Medical Research Centre, North East Region (Indian Council of
Medical Research). Smokers, chewers and drinkers were classified
into two categories ever and never. For smoking, an individual
who had never smoked or smoked less than 100 cigarettes in their
lifetime and were not smoking at the time of reporting was
considered never smoker or non-smokers. Ever smokers or
smokers category included current smokers, and those who had
quit within ,1 year of reporting [6]. 5 ml of blood was collected in
EDTA vials and stored under -70uC until processed.
Genotyping
Genomic DNA was isolated using Qiagen Blood DNA Isolation
kit (Qiagen GmbH, Germany) and stored at 230uC till further
analysis. Details for SNPs selected for the study are summarized in
Table S1. The deletion variants in GSTM1 and GSTT1 were
determined by multiplex polymerase chain reaction protocol and
SNPs in CYP1A1, EPHX1, GSTP1, SULT1A1 were determined by
polymerase chain reaction–restriction fragment length polymor-
phism assays as previously described [7–12]. 10% of the randomly
selected cases and controls were genotyped twice for each SNP,
however no discrepancies were observed.
Statistical Analysis
Cases were individually matched with controls on the basis of
age (65 years), sex and ethnicity, in a ratio of approximately 1:1.5.
Difference in the distribution of demographic characteristics and
genotype frequencies between cases and controls were evaluated
using the Chi Square (x
2) and Fisher’s Exact test wherever
appropriate. Hardy–Weinberg equilibrium (HWE) was assessed by
using the x
2-test. Estimates of risk to cancer, imparted by
genotypes and other covariates as tobacco smoking, tobacco
chewing, betel quid chewing and alcohol consumption were
determined by deriving the odds ratio (OR) and its corresponding
95% confidence interval (95% CIs) using multivariable conditional
logistic regression. For all the tests a two sided p,0.05 was
considered statistically significant. The data analysis was per-
formed on the Intercooled Stata 8.0 statistical software package
(Stata Co., College Station, TX).
Haplotype Analysis
Haplotypes were constructed from the unphased diploid
genotype data using the Expectation Maximization-based algo-
rithm. Individual haplotypes and their estimated population
frequencies were inferred and estimates of linkage disequilibrium
(D’) between SNPs were calculated using Haploview software
ver.4.1.
Identification of High Order Interactions
High order interactions were determined using CART, MDR
and interaction entropy graphs.
CART. A binary recursive partitioning method was used to
produce a decision tree that identified specific combinations of
contributing factors associated with lung cancer risk using the
commercially available CART software (version 6.6, Salford
Systems) [13]. Tree splitting was done till terminal nodes
reached a pre- specified minimum size of 10 subjects. Optimal
tree was selected using one standard error (1-SE) rule and 10 fold
cross validation. Subgroups of individuals with differential risk
patterns were identified in the different order of nodes, indicating
the presence of gene-gene and gene-environment interactions.
Fischer’s Exact test was used to calculate relative risk in each
terminal node of the tree.
MDR. The MDR software was developed by Ritchie et. al.
in 2001 [4] and reviewed by Moore et al [14]. Genotype and
Gene-Environment Interactions in Lung Cancer
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effectively reducing the multifactor prediction from n dimension
to one dimension using MDR software (version 2.0 beta)
(http://www.epistasis.org). We applied Tuned ReliefF (TuRF)
filter algorithm to remove noisy SNPs and avoid overfitting of
data. Best models for each locus were selected by repeating the
analysis for up to 10 seeds and applying 10 folds cross validation
each time. Statistical significance of the best models selected for
each locus was determined using 1000 fold permutation testing.
p-values hence obtained for TBA and cross validation
consistency (CVC), were considered statistically significant at
0.05 levels.
False Positive Report Probability (FPRP)
Reports of gene-environment interaction studies are often
challenged by false positive discoveries especially when results
are generated by multiple comparisons. To estimate the FPRP
and to evaluate robustness of the findings from MDR analysis we
used the Bayesian approach described by Wacholder et. al. [15].
The method requires prior probabilities that the genetic variant
and disease association is real. As prior probability can be a
subjective measure and can be influenced by several factors,
usually a wide range is reported by studies. Considering poor
epidemiological data from the study population and inconsistent
association of the SNPs with lung cancer risk we set a fairly wider
range of prior probabilities (10
26 to 10
21)w i t ha ne s t i m a t e d
statistical power to detect an OR of 1.5 and 2.0 and a level equal
to the observed p-value. The FPRP cutoff point was stringently
kept to 0.2.
Interaction entropy graphs
Interaction graphs were built to visualize and interpret the
results obtained from MDR using Orange machine learning
software package [16]. Interaction graphs use entropy estimates as
described by Jakulin et al. [17] for determining the gain in
information about a class variable (e.g. case–control status) from
merging two variables together over that provided by the variables
independently. This measure of entropy is useful for building
interaction graphs that facilitate the interpretation of the
relationship between variables. Interaction graphs are comprised
of a node for each variable with pairwise connections between
them. The percentage of entropy removed (i.e. information gain)
by each variable is visualized for each node. The percentage of
entropy removed for each pairwise Cartesian product of variables
was visualized for each connection. Thus, the independent main
effects of each SNP can be compared to the interaction effect.
Positive entropy (plotted in green) indicates non-linear interaction
while negative entropy (plotted in red) indicates redundancy.
Entropy value equal to zero indicates independence or a mixture
of synergy and redundancy.
Results
Characteristics of study subjects
The distribution of gender and ethnicity was similar for cases
and controls. The frequency distribution of males and females
were 77.1% and 22.9% in cases and 76.2% and 23.85 in controls
respectively. Mean age of cases and controls was 60.41610.58
(range 30–82 yrs) and 57.19610.75 (range 32–85 yrs) respectively.
The distribution of all SNPs in control was in agreement with
HWE (p.0.05), however alleles of EPHX1 Tyr113His and
SULT1A1 Arg213His polymorphisms in cases did not follow
HWE (p,0.001 and p=0.004 respectively).
Association of genetic and environmental factors with
lung cancer risk by LR analysis
The distribution and main effects of genetic and environmental
factors is summarized in Table 1. Risk habits such as smoking,
tobacco chewing and betel quid chewing were predominant
among cases. However only smoking and betel quid chewing were
significantly associated with increased risk for lung cancer
(OR=3.06;95%CI=1.9424.83;p,0.001 and OR=1.86; 95%CI
=1.2122.84;p=0.004 respectively). Genotype distribution of
CYP1A1*2A, EPHX1 Tyr113His, SULT1A1 Arg213His and
GSTT1 null polymorphism were significantly different in cases
from controls (p=0.014, p,0.001, p=0.01 and p=0.04 respec-
tively). Main effects of genotypes in lung cancer susceptibility were
evaluated using conditional multivariable logistic regression.
Heterozygous genotype in CYP1A1*2A was associated with
increased risk (OR=1.69,95% CI=1.1122.59; p=0.01) whereas
heterozygous genotypes in EPHX1 Tyr113His and SULT1A1
Arg213His imparted reduced risk towards lung cancer (OR
=0.40;95%C.I=0.2520.65,p,0.001 and OR=0.51;p=0.33x2
0.78,p=0.002 respectively). CYP1A1*2A and EPHX1 His139Arg
polymorphisms were associated with increased risk to lung cancer in
dominant genetic model, whereas EPHX1 Tyr113His and SULT1A1
Arg213His imparted reduced risk in recessive genetic model (Table
S2).
Haplotype analysis
Table 2 summarizes the associations between the frequency
distributions of the haplotypes in CYP1A1 and EPHX1 genes and
the risk of lung cancer. The odds ratios were calculated using the
most common haplotype as the reference group. In CYP1A1,
‘‘TA’’ haplotype was the most frequent among both cases and
controls and showed significant association. Only CYP1A1-CG
haplotype imparted increased risk to lung cancer (OR=1.49;95%-
CI=1.0022.21,p=0.04). In EPHX1, the ‘‘TA’’ haplotype was the
most common with frequencies of 44.79% and 45.04% in cases
and controls respectively. No haplotype was found to be
significantly associated with lung cancer risk.
Risk associated with SNPs stratified by smoking
Since smoking is a well established risk factor to lung cancer and
was the strongest independent risk factor in LR, we further
stratified the data by smoking status. Distribution and risk
associated with genetic factors after stratification is shown in
Table 3. Heterozygous and homozygous variant genotypes of
CYP1A1*2A polymorphism imparted significant risk in non-
smokers (OR=2.88;95%CI=1.2226.81,p=0.016 and OR=
4.35;95%CI=1.47212.84,p=0.008). Also, CYP1A1*2C variant
genotype and GSTP1 Ile105Val heterozygous genotype were
significantly associated with increased risk in non-smokers
(OR=11.81;95%CI=1.242111.98,p=0.03 and OR=2.40;95%
CI=1.1525.03,p=0.01). Heterozygous genotypes in EPHX1
Tyr113His and SULT1A1 Arg213His were associated with 66%
and 55% reduced risk in smokers (OR=0.34;95%CI=0.18
20.63,p=0.001 and OR=0.45;95%CI=0.2520.80,p=0.007
respectively). However heterozygous genotype in EPHX1 Hi-
s139Arg conferred significant risk in smokers (OR=1.92;95%-
CI=1.0723.45,p=0.02).
CART analysis
Figure 1 shows the selected CART model constructed on all
investigated genetic variants and environmental risk factors. The
final tree contained eight terminal nodes. The first split of the root
node was on smoking habit, indicating that smoking is the
Gene-Environment Interactions in Lung Cancer
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subsequent splits showed interactions between EPHX1 Tyr113His,
SULT1A1 Arg213His and GSTM1. In non-smokers first split was
on CYP1A1*2A status, which was in concordance with the LR
analysis where CYP1A1*2A showed strong association to risk only
in nonsmokers. Further interactions were predicted by SULT1A1
Arg213His polymorphism and betel quid status. Terminal node 7,
which comprised of least percentage of cases in non-smokers, was
taken as reference to calculate OR for other terminal nodes.
Among smokers maximum risk was observed for terminal node1
consisting of EPHX1 113TT (Tyr/Tyr) or -113CC (His/His)
genotypes (OR=4.38;95%CI=2.1229.15) and for terminal node
2 with combination of EPHX1 113TC (Tyr/His), SULT1A1
213GG (Arg/Arg) or AA (His/His) and GSTM1 null genotypes
(OR= 3.73;95%CI=1.33210.55, p=0.006). In non-smokers
high risk was seen for terminal node 5 comprising of CYP1A1*2A
6235CC or TC, SULT1A1 213GG (Arg/Arg) and betel quid
chewing (OR=2.93;95%CI=1.1527.51, p= 0.01). Parallel to
the above, CART analysis on separate data sets of smokers and
non-smokers was also performed. However, we did not detect any
high-order interaction in these analyses (data not shown).
MDR Analysis
MDR analysis was applied to further explore gene-gene and
gene-environment interactions. Best predictive models up to 4
orders of interaction, along with their CVC and TBA are
summarized in Table 4. The analysis was run separately for total
data set and data sets stratified on smoking status. For total data
Table 1. Association of genotypes of xenobiotic metabolizing genes and environmental risk factors with lung cancer
susceptibility.
FACTORS CATEGORIES GENOTYPE CASES CONTROLS OR (95% C.I.) p value
Genetic Factors
# n% n%
CYP1A1*2A
a TT T6235T 55 29.3 122 42.1 1..0
TC T6235C 103 54.8 124 42.8 1.69 (1.11–2.59) 0.01
CC C6235C 30 16.0 44 15.2 1.53 (0.84–2.78) 0.15
CYP1A1*2C AA Ile462Ile 122 64.9 206 71.0 1..0
AG Ile462Val 56 29.8 77 26.6 1.16 (0.75–1.80) 0.48
GG Val462Val 10 5.3 7 2.4 2.18 (0.78–6.09) 0.13
EPHX1 Tyr113His
a TT Tyr113Tyr 82 43.6 94 32.4 1.0
TC Tyr113His 51 27.1 133 45.9 0.40 (0.25–0.65) ,0.001
CC His113His 55 29.3 63 21.7 1.00 (0.60–1.67) 0.98
EPHX1 His139Arg AA His139His 121 64.4 212 73.1 1.0
AG His139Arg 59 31.4 70 24.1 1.45 (0.92–2.27) 0.10
GG Arg139Arg 8 4.3 8 2.8 2.41 (0.79–7.36) 0.12
GSTM1 Wild Type Present 122 64.9 177 61.0 1.0
Null Null Genotype 66 35.1 113 39.0 0.95 (0.63–1.41) 0.80
GSTT1
a Wild Type Present 155 82.4 217 74.8 1.0
Null Null Genotype 33 17.6 73 25.2 0.62 (0.38–1.02) 0.06
GSTP1 AA Ile105Ile 102 54.3 179 61.7 1.0
AG Ile105Val 77 41.0 96 33.1 1.46 (0.95–2.23) 0.07
GG Val105Val 9 4.8 15 5.2 1.09 (0.43–2.77) 0.84
SULT1A1
a GG Arg213Arg 123 65.4 153 52.8 1.0
GA Arg213His 50 26.6 116 40.0 0.51 (0.33–0.78) 0.002
AA His213His 15 8.0 21 7.2 0.87 (0.42–1.82) 0.72
Environmental Factors
##
Smoking status
a Non-smokers 56 29.8 151 52.1 1.0
Smokers 132 70.2 139 47.9 3.06 (1.94–4.83) ,0.001
*
Tobacco chewing
a Non-chewers 92 48.9 172 59.3 1.0
Chewers 96 51.1 118 40.7 1.24 (0.82–1.85) 0.293
Betel quid chewing
a Non chewers 52 27.7 131 45.2 1.0
Chewers 136 72.3 159 54.8 1.86 (1.21–2.84) 0.004
*
Alcohol consumption Non-alcoholic 135 71.8 207 71.4 1.0
Alcoholic 53 28.2 83 28.6 0.87 (0.56–1.37) 0.57
ax
2 significant; p,0.05.
#ORs adjusted for all environmental factors.
##ORs adjusted for all genetic factors.
*Significant after p-value adjustment for multiple comparision (Sidak correction).
doi:10.1371/journal.pone.0029431.t001
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10) and testing accuracy of 0.6114 which was statistically
significant (p,0.001) determined by 1000 fold permutation
testing. For a 2-locus interaction, combination of smoking and
EPHX1 Tyr113His was most significant with CVC of 10/10 and
TBA of 0.6407 (p,0.001). The 3 locus model consisted of
smoking, EPHX1 Tyr113His and EPHX1 His139Arg with TBA of
0.6497 (p,0.001) and CVC of 10/10. The 4 loci interaction
model of smoking, EPHX1 Tyr113His, EPHX1 His139Arg and
SULT1A1 Arg213His, was the best model identified, with
maximum CVC (10/10) and TBA (0.6503, p,0.001). This model
had a chi-square value of 66.31 (p,0.0001) and an OR of 4.93
(95%CI=3.3227.33). In smokers the best interaction model was
the three loci model consisting of tobacco chewing, EPHX1
Tyr113His and SULT1A1 Arg213His having maximum CVC (10/
10) and TBA (0.6436, p,0.001) among all models identified. The
Table 2. Distribution of CYP1A1 and EPHX1 haplotype frequency among lung cancer cases and controls.
HAPLOTYPE CASE ( 376) CONTROL ( 580) x
2 P value OR (95%CI) P value D’
%n % n
CYP1A12A*2C TA 53.34 201 60.80 352 5.00 0.02 1.00 0.72
TG 3.31 12 2.65 16 0.21 0.64 1.31 (0.57–3.00) 0.50
CA 26.45 99 23.51 137 0.95 0.32 1.26 (0.91–1.74) 0.15
CG 16.90 64 13.04 75 2.94 0.08 1.49 (1.00–2.21) 0.04
EPHX1 Tyr113His * His139Arg TA 44.79 168 45.04 262 0.05 0.81 1.00 0.21
TG 12.39 47 10.31 59 1.57 0.20 1.23(0.78–1.94) 0.30
CA 35.26 133 40.13 233 1.82 0.17 0.88 (0.65–1.19) 0.42
CG 7.56 28 4.52 26 2.64 0.10 1.67 (0.91–3.06) 0.07
D’ Linkage Disequilibrium.
doi:10.1371/journal.pone.0029431.t002
Table 3. Main effects of genotypes on lung cancer risk stratified by smoking.
Polymorphism Genotype Smoker Non Smoker
Case/Control (n,%) OR (95% C.I.),p value
* Case/Control (n,%) OR (95% C.I.),p value
*
CYP1A1*2A TT 44(33.3)/57(41.0) 1.0 11(19.6)/65(28.6) 1.0
TC 74(56.1)/61(43.9) 1.45(0.84–2.50),0.17 29(51.8)/63(41.7) 2.88(1.22–6.81),0.016
CC 14(10.6)/21(15.1) 0.83(0.36–1.91),0.66 16(28.6)/23(15.2) 4.35(1.47–12.84),0.008
#
CYP1A1*2C AA 86(65.2)/93(66.9) 1.0 36(64.3)/113(74.8) 1.0
AG 40(30.3)/40(28.8) 1.14(0.65–2.02),0.63 16(28.6)/37(24.5) 1.53(0.67–3.48),0.30
GG 6(4.5)/6(4.3) 1.71(0.43–6.74),0.43 4(7.1)/1(0.7) 11.81(1.24–111.98),0.03
EPHX1 Tyr113His TT 60(45.5)/41(29.5) 1.0 22(39.3)/53(35.1) 1.0
TC 35(26.5)/71(51.1) 0.34(0.18–0.63),0.001
# 16(28.6)/62(41.1) 0.62(0.25–1.54),0.30
CC 37(28.0)/27(19.4) 1.14(0.57–2.29),0.69 18(32.1)/36(23.8) 1.03(0.41–2.56),0.94
EPHX1 His139Arg AA 80(60.6)/103(74.1) 1.0 41(73.2)/109(72.2) 1.0
AG 48(36.4)/32(23.0) 1.92(1.07–3.45),0.02 11(19.6)/38(25.2) 0.98(0.41–2.36),0.98
GG 4(3.0)/4(2.9) 1.39(0.31–6.25),0.66 4(7.1)/4(2.6) 4.25(0.54–33.15),0.16
GSTM1 WildType 91(68.9)/86(61.9) 1.0 31(55.4)/91(60.3) 1.0
Null 41(31.1)/53(38.1) 0.87(0.51–1.48),0.62 25(44.6)/60(39.7) 1.25(0.61–2.54),0.53
GSTT1 WildType 106(80.3)/104(74.8) 1.0 49(87.5)/113(74.8) 1.0
Null 26(19.7)/35(25.2) 0.75(0.40–1.41),0.37 7(12.5)/38(25.2) 0.48(0.19–1.20),0.11
GSTP1 AA 69(52.3)/77(55.4) 1.0 33(58.9)/102(67.5) 1.0
AG 54(40.9)/55(39.6) 1.35(0.77–2.36),0.29 23(41.1)/41(27.2) 2.40(1.15–5.03),0.01
#
GG 9(6.8)/7(5.0) 1.49(0.49–4.56),0.47 0/8(5.3) NA
SULT1A1 GG 84 (63.6)/69 (49.6) 1.0 39(69.6)/84(55.6) 1.0
GA 35 (26.5)/58 (41.7) 0.45(0.25–0.80),0.007
# 15(26.8)/58(38.4) 0.54(0.24–1.19),0.13
AA 13 (9.8)/12 (8.6) 1.11(0.45–2.74),0.81 2(3.6)/9(6.0) 0.48(0.09–2.54),0.39
*p values adjusted for tobacco chewing, betel quid chewing and alcohol consumption.
#Significant after p-value adjustment for multiple comparision (Sidak correction).
doi:10.1371/journal.pone.0029431.t003
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(95%CI=2.6927.69). In non-smokers the best model was the
three loci model comprising of CYP1A1*2A, GSTP1 Ile105Val and
SULT1A1 Arg213His with CVC of 10/10 and TBA of 0.6677
(p,0.005) and an OR of 7.32 (95%CI=3.24216.53).
False positive report probability (FPRP)
Table 5 shows the FPRPs for the 3 best models obtained from
MDR analysis. The 4-loci predictor model on total data set and 3-loci
model in smokers showed excellent reliability even when assuming
very low prior probabilities (from 10
23 to 10
26) for detecting ORs of
1.5 and 2.0. However the best model selected in non smoker category
showed true association only at high probability of 10
21 for detecting
OR=1.5 and till 10
22 for detecting OR=2.0.
Interaction entropy graphs
After identifying the high-risk combinations using MDR
approach, interaction entropy algorithm was applied to interpret
relationship between the variables. Graphs were constructed on
MDR results obtained from analysis on total data set (Figure S1)
and on data set stratified by smoking (Figure 2). In smokers,
EPHX1 Tyr113His had a large independent effect (4.64%) and a
non-additive interaction with tobacco chewing (entropy 1.79%).
Considerable entropy was associated with SULT1A1 Arg213His
(1.88%) and its interaction with tobacco chewing further removed
1.49% of entropy from case-control group. However we did not
detect any non-linear interaction between the two SNPs in the
model. We found small percentages of the entropy in case–control
status explained by alcohol consumption (0.56%) and tobacco
chewing (0.70%) independently, but a large percentage of entropy
explained by the interaction between these two environmental
factors (2.47%). In non-smokers, CYP1A1*2A showed strongest
main effect with entropy removal of 4.7%. GSTP1 Ile105Val too
had a strong independent effect (entropy removal=3.28%) and its
interaction with SULT1A1 Arg213His further removed 3.02% of
entropy. A strong synergistic interaction was observed between
Figure 1. Classification and regression tree model for xenobiotic metabolizing gene polymorphisms and environmental risk
factors. Terminal nodes are thick bordered.
*W: Wild type genotype; V: Variant genotype, TN: Terminal Node,
#p value ,0.05.
doi:10.1371/journal.pone.0029431.g001
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removed an additional 2.61% of the total entropy.
Discussion
The present study used multiple analytical methods to first
assess associations and then explore possible interactions of
xenobiotic metabolizing genes with environmental factors in risk
to lung cancer. The applied data mining approaches have the
ability to search and identify interactions regardless of the
significance of the main effects. The most significant finding of
this study is the consistently identified gene-gene and gene
environment interactions by all the three statistical approaches.
Smoking is the primary etiological factor in lung cancer. The
same was reflected in the present study as smoking showed strong
association in LR, best one factor model in MDR and formed first
split in CART. Interaction of EPHX1 Tyr113His and SULT1A1
Arg213His was consistently identified in smokers. Both EPHX1
Tyr113His and SULT1A1 Arg213His conferred reduced risk in
smoker subset in LR. The two polymorphisms along with EPHX1
His139Arg formed the best predictor model in MDR analysis in
smokers and also formed subsequent splits within smokers in
CART. EPHX1 enzyme catabolizes epoxides from PAH into
dihydrodiols, which involves generation of more reactive carcino-
genic metabolites. Substitution of a variant His allele at codon 113
(EPHX1 Tyr113His) decreases the activity of this enzyme [18]
thereby reduces the risk of cancer. Studies on lung cancer suggest
protective effect for His113 (slow type) as compared to Tyr113 (fast
type) which imparts increased lung caner risk [19–21]. The variant
allele has also been suggested to decrease the risk of ovarian cancer
[22]. We have earlier reported similar results from the same
population in esophageal cancer showing His113 allele to be
associated with a significantly reduced risk in smokers [23].
Reflecting the same, in CART analysis Terminal node 1 of
imparts over 4 fold high risk to smokers possibly due high
proportion of the wild Tyr113 homozygous genotype. Sulphona-
tion reaction of SULT1A1 is a detoxification reaction, however it
also involves bioactivation of certain procarcinogens, including
heterocyclic amines and PAHs to form carcinogen-DNA adduct
[24,25]. In vitro model studies suggest that substitution of histidine
at position 213 in the amino acid sequence is associated with
decreased substrate affinity and a lower level of protein [26] which
might protect against chemical carcinogenesis of PAHs in lung
cancer [27]. Results on association of SULT1A1 Arg213His and
risk of cancer are inconsistent, from null association with risk of
colorectal cancer [28] and prostate cancer [29] to increase in risk
of breast cancer associated with His213 allele [30]. Another study
on colorectal cancer showed a significantly reduced risk for
individuals carrying His213 allele [31]. A Meta-analysis by Kotnis
et al [32] showed a significant protective effect of the polymor-
phism in seven studies of genitourinary cancers.
Among non-smokers CYP1A1*2A and GSTP1 Ile105Val were
the most important polymorphisms identified for lung cancer
development. The variant allele of both the polymorphisms
conferred significant risk in the non smoking subgroup in LR
analysis. Similarly, MDR 3 loci model of CYP1A1*2A, GSTP1
Ile105Val and SULT1A1Arg213His polymorphisms was the best
predictor of risk in non-smokers. The CYP1A1 6235T.C MspI
(CYP1A1*2A) polymorphism, is associated with higher enzymatic
activity towards benzopyrene [33,34]. Investigations on associa-
tion between CYP1A1 polymorphisms and lung cancer have
yielded equivocal results [35,36]. Similar to our findings, a study
by Taioli et. al. [37] reported association of CYP1A1*2A variant
allele with lung cancer, however after stratification by smoking the
association remained confined to non-smokers only. Further, in a
pooled analysis of 11 studies on CYP1A1*2C polymorphism in lung
cancer, Le Marchand et al [38] found it to be associated with risk
in non-smokers, a finding which corroborates our results. Another
study by Jose et al [39] on lung cancer found no association of any
CYP1A1 polymorphism with smokers. Similar results were
reported in colorectal cancer where heterozygous and variant
genotypes of both CYP1A1*2A and CYP1A1*2C conferred risk in
Table 4. Results of MDR analysis.
No. of Locus Model p value (x
2 test) TBA p-value* CVC p-value*
Total Data Set
1st order Smk p , 0.0001 0.6114 ,0.001 10 0.391
2
nd order Smk Ex3 p , 0.0001 0.6407 ,0.001 10 0.391
3
rd order Smk Ex3 Ex4 p , 0.0001 0.6497 ,0.001 10 0.391
4
th order** Smk Ex3 Ex4 SULT p , 0.0001 0.6503 ,0.001 10 0.391
Smokers
1st order Ex3 p , 0.0001 0.6228 0.012 10 0.402
2
nd order Tbc Ex3 p , 0.0001 0.6105 ,0.02 9 0.623
3
rd order** Tbc Ex3 SULT p , 0.0001 0.6436 ,0.001 10 0.402
4
th order Tbc Alc Ex3 SULT p , 0.0001 0.6268 ,0.008 7 0.846
Non Smokers
1st order 2A p = 0.0019 0.6170 0.09 10 0.372
2
nd order 2A SULT p = 0.0004 0.5562 0.46 8 0.734
3
rd order** 2A P1 SULT p , 0.0001 0.6677 ,0.005 10 0.372
4
th order 2A 2C P1 SULT p , 0.0001 0.6439 ,0.021 10 0.372
*1,000-fold permutation test. **Best models selected with maximum cross-validation consistency (CVC) and maximum testing balance accuracy (TBA). Labels: Smk:
smoking, Ex3: EPHX1 Tyr113His, Ex4: EPHX1 His139Arg, SULT: SULT1A1 Arg213His, Tbc: tobacco chewing, Alc: alcohol consumption, 2A: CYP1A1*2A,P 1 :GSTP1 Ile105Val,
2C: CYP1A1*2C.
doi:10.1371/journal.pone.0029431.t004
Gene-Environment Interactions in Lung Cancer
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29431combinations with NAT2 only among non-smokers [40]. In vitro
cDNA expression study suggests that GSTP1 with 105Val variant
results in a protein with reduced enzyme activity [41], however it is
reported to play an unlikely role for smoking-related cancers [42].
Similar observation has been reported from breast cancer [10].
Probably the precise role of GSTP1 in carcinogenesis can be
determined by the kind of xenobiotic involved owing to its
substrate specificity and affinity [43].
Confirming to its exploratory nature, CART analysis identified
two more risk factors, GSTM1 null genotype in smokers and betel
quid chewing in non-smokers. The results are quite plausible
because both hold functional and biological significance. High risk
for smoking related lung cancer has been reported in individuals
deficient in GSTM1 [44–46]. Smokers with the GSTM1 enzyme
have approximately one-third of the risk for lung carcinoma than
smokers without the enzyme [47]. There are numerous reports of
association between GSTM1 null genotype and smoking in various
cancers including esophageal [48], bladder [49] colorectal [50]
and oral [51]. A recent study by Wen et. al. [52] showed betel quid
chewing increases lung cancer risk in non-smokers, with smoking
habit further enhancing the risk. Betel quid chewing is a unique
and widespread habit in the north-eastern (NE) region of India.
Betel quid is a chewing mixture of whole betel/areca nut wrapped
with betel leaves spread with white lime with frequent addition of
tobacco. It is known to contain phenolic compounds and alkaloids,
besides nitrosamines are formed from an in vivo reaction of betel
arecoline, nitrite and thiocynate, all of which act as carcinogens
[53]. Studies have reported association between betel quid
chewing and cancer risk. Significant association of betel quid
chewing with risk of oral, stomach [54] esophageal [23] and breast
cancer [55] has been reported from the study population. It would
T
a
b
l
e
5
.
F
a
l
s
e
p
o
s
i
t
i
v
e
r
e
p
o
r
t
p
r
o
b
a
b
i
l
i
t
y
a
n
d
o
d
d
s
r
a
t
i
o
f
o
r
b
e
s
t
m
o
d
e
l
o
f
M
D
R
a
n
a
l
y
s
i
s
.
O
R
(
9
5
%
C
I
)
p
v
a
l
u
e
O
R
=
1
.
5
P
r
i
o
r
P
r
o
b
a
b
i
l
i
t
y
O
R
=
2
.
0
P
r
i
o
r
P
r
o
b
a
b
i
l
i
t
y
P
o
w
e
r
1
0
2
1
1
0
2
2
1
0
2
3
1
0
2
4
1
0
2
5
1
0
2
6
P
o
w
e
r
1
0
2
1
1
0
2
2
1
0
2
3
1
0
2
4
1
0
2
5
1
0
2
6
T
o
t
a
l
D
a
t
a
S
e
t
S
m
k
E
x
3
E
x
4
S
U
L
T
4
.
9
3
(
3
.
3
2
–
7
.
3
3
)
p
,
0
.
0
0
0
1
0
.
0
0
0
1
,
1
0
2
4
,
1
0
2
4
0
.
0
0
1
0
.
0
1
5
0
.
1
3
1
0
.
1
3
1
0
.
0
0
0
1
,
1
0
2
4
,
1
0
2
4
,
1
0
2
4
,
1
0
2
4
,
1
0
2
4
,
1
0
2
4
S
m
o
k
e
r
s
T
b
c
E
x
3
S
U
L
T
4
.
5
5
(
2
.
6
9
–
7
.
6
9
)
p
,
0
.
0
0
0
1
0
.
0
0
0
1
0
.
0
0
8
0
.
0
8
1
0
.
4
7
2
0
.
9
0
0
0
.
9
8
9
0
.
9
8
9
0
.
0
0
1
,
1
0
2
4
0
.
0
0
1
0
.
0
1
4
0
.
1
2
5
0
.
5
8
8
0
.
5
8
8
N
o
n
S
m
o
k
e
r
s
2
A
P
1
S
U
L
T
7
.
3
2
(
3
.
2
4
–
6
.
5
3
)
p
,
0
.
0
0
0
1
0
.
0
0
0
1
0
.
1
8
0
0
.
7
0
8
0
.
9
6
1
0
.
9
9
6
1
.
0
0
1
.
0
0
0
.
0
0
1
0
.
0
1
6
0
.
1
5
5
0
.
6
5
0
0
.
9
4
9
0
.
9
9
5
0
.
9
9
5
P
r
i
o
r
p
r
o
b
a
b
i
l
i
t
i
e
s
r
a
n
g
i
n
g
f
r
o
m
0
.
1
t
o
1
0
2
6
,
w
i
t
h
t
h
e
e
s
t
i
m
a
t
e
d
s
t
a
t
i
s
t
i
c
a
l
p
o
w
e
r
t
o
d
e
t
e
c
t
a
n
O
R
o
f
1
.
5
o
r
2
.
0
w
i
t
h
a
l
e
v
e
l
e
q
u
a
l
t
o
t
h
e
o
b
s
e
r
v
e
d
p
-
v
a
l
u
e
.
B
o
l
d
t
y
p
e
i
n
d
i
c
a
t
e
s
t
h
e
F
P
R
P
f
o
r
t
h
e
m
o
s
t
l
i
k
e
l
y
p
r
i
o
r
p
r
o
b
a
b
i
l
i
t
i
e
s
i
.
e
.
a
n
o
t
e
w
o
r
t
h
y
a
s
s
o
c
i
a
t
i
o
n
a
t
t
h
e
0
.
2
F
P
R
P
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
2
9
4
3
1
.
t
0
0
5
Figure 2. Interaction entropy graphs. The interaction model
describes the percentage of the entropy (information gain) removed
by each variable (main effect: represented by nodes) and by each
pairwise combination of attributes (interaction effect: represented by
connections). Attributes are selected on the basis of MDR results
obtained in case of (A) Smokers and (B) Non smokers. Labels: Ex3:
EPHX1 Tyr113His, Alc: alcohol consumption, Tbc: Tobacco chewing,
SULT: SULT1A1 Arg213His, 2A: CYP1A1*2A, 2C: CYP1A1*2C, P1: GSTP1
Ile105Val.
doi:10.1371/journal.pone.0029431.g002
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with lung cancer is a result of a complex combination of direct and
indirect action of tobacco carcinogens contained in it.
A post-hoc analysis through entropy graph was done to visualize
and interpret interaction models identified by MDR. The
previously documented main effects of EPHX1 Tyr113His and
SULT1A1 Arg213His in smokers and CYP1A1*2A and GSTP1
Ile105Val in non-smokers were evident. Further, synergistic
interactions of SULT1A1 Arg213His with GSTP1 Ile105Val and
with CYP1A1*2C were observed in non-smokers.
As haplotype are more efficient and informative than separate
markers, haplotype association analysis was carried out in CYP1A1
and EPHX1 genes. CG haplotype in CYP1A1 was significantly
associated with risk of lung cancer. Noteworthy were results in
EPHX1, where frequency of haplotypes among cases was strikingly
similar to report published in esophageal cancer from north India
[56].
Although both MDR and CART validated LR results, yet
they differed in identifying some unique interactions, reflecting
different methods followed by each program. Both approaches
provide a clear advantage over the traditional LR by identifying
non-linear interactions among discrete genetic and environmen-
tal attributes. Significant findings of the study are summarized in
Figure S2. It would be safe to assume a definite association of the
commonly recognized factors to lung cancer that might have
implications on future studies. Role of CYP1A1*2A polymor-
phism is evident only among non smokers in all the three
methods. LR and CART analyses even showed a gene-dosage
effect for the increased lung cancer risk with the increasing
number of variant allele in the CYP1A1*2A polymorphism. As
aforesaid, this finding provides support to previously published
reports [37–40]. MDR and CART analysis show epitasis
between EPHX1 Tyr113His and SULT1A1 Arg213His polymor-
phisms exclusively among smokers. Their combined models
confer risk to lung cancer however individually both act as
protective factors in smokers only. These factors hold their
importance as the SNPs are functionally and biologically
relevant and have been implicated in the carcinogenesis process
in previous studies on various cancers
Major challenge for the identification of true genetic and
interactive effects in a multi-factorial study is simultaneous testing
of several hypotheses. The three methods of analysis used in this
study address the same research hypotheses but differ in terms of
their statistical methodologies and analytical approaches. P-value
adjustment for multiple testing was performed through SIDAK
correction in LR model with the equality as (1-(1-a)
1/n) where
n=4 both in total and stratified analyses. Multiple testing in data
mining approaches such as CART and MDR sometimes
compromises upon the comparative power. When numerous null
hypotheses are being tested yielding higher order interacting
combinations the inference drawn from a single erroneous
rejection is not an appropriate strategy, rather the proportion of
erroneous rejection needs to be controlled. This is achieved by
estimation of FPRP. These approaches utilize internal cross-
validations and permutation testing of p-value reducing the
chances of making type I errors. Both MDR and CART apply
cross validation of data before selecting the best model however
MDR also uses 1000 fold-permutation testing, to validate its
results for minimizing the proportion of false-positives due to
multiple testing. The cross validation (5–10 fold) dividing the
whole data set into different sets of training and testing set prevents
over-fitting and artificial accuracy improvement. Permutation test
is considered the gold standard for accurate multiple testing
correction. Controlling for false discovery rate (FDR) is a more
realistic approach than as compared to concerns raised by the
multiple hypothesis testing. This is because FDR is the proportion
of incorrect rejection among all such rejections. Likewise, the best
models derived from MDR on total data set and smokers set in this
study showed good reliability as associations remained robust even
at low prior probabilities for FPRP testing. CART analysis was
able to define genetic associations with fairly good measures.
Correct classification of cases and controls in test data set was
approximately 63% for both.
There might be some limitations to this study. The sample size
of our study was relatively small, however based on the evidences
(OR) provided by our research group on association between GSTs
with lung cancer [57], the minimum sample size determined was
176 at 5% level of significance and 90% power. Polymorphisms of
EPHX1 Tyr113His and SULT1A1 Arg213His in cases showed
deviation from HWE. After ruling out false positive associations
and genotyping errors perhaps population stratification, could be a
reason for this deviation. However, the cases were incident, and
thus, the data do not show report or recall bias. Also case-control
matching was done in reference to age, gender, and ethnicity,
thereby controlling for any confounding effect accounted by these
variables.
In conclusion this study highlights that better predictors for lung
cancer risk can be obtained through polygenic approaches and
exploring gene-environment interactions. The study identified
distinct patterns of interaction in smoking and non smoking sub
groups. However, the results presented should be treated with
caution since this is the first epidemiological evidence identifying
the complex relationship between genetic polymorphisms and
cancer susceptibility in the studied population. Further studies with
large samples in independent populations are warranted to
validate the findings of this study.
Supporting Information
Figure S1 Interaction entropy graphs (for total data
set). The interaction model describes the percentage of the
entropy (information gain) removed by each variable (main effect:
represented by nodes) and by each pairwise combination of
attributes (interaction effect: represented by connections). Attri-
butes are selected on the basis of MDR results obtained in case of
total data set. Labels: Smk: smoking, SULT: SULT1A1
Arg213His, Ex3: EPHX1 Tyr113His (EH3), Ex4: EPHX1
His139Arg, SULT.
(TIFF)
Figure S2 Summarized results for LR, MDR and CART
analyses. Green boxes indicate OR,1. Red boxes indicate
OR.1. For MDR and CART significant interactions are shown.
LR results should be read individually. Alcohol was excluded as it
did not appear significant in any analysis.
(TIF)
Table S1 Detailed list of xenobiotic genes and polymor-
phisms analyzed in the study. *Chromosomal position is
based on NCBI Build 36.2 (National Center for Biotechnology
Information, Bethesda, MD). ** Base pair
#mentioned in text as
CYP1A1*2A
##mentioned in text as CYP1A1*2C
$Not Applicable
{internal control for GSTM1 and GSTT1 multiplex.
(DOC)
Table S2 Genotype representation and associations
under dominant and recessive model between cases
and controls.
*crude odds ratio
**odds ratio adjusted for
smoking, tobacco chewing, betel quid chewing and alcohol.
(DOC)
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